Stock Screener App

無料 -

インストール

0.016

8.11% 0.0012

after-market

アフターアワーズ： .02 0.004 +25.00%

Nls Pharmaceutics Ag (NLSPW)

概要ニュース株価時系列ディスカッション予測

Nls Pharmaceutics Ag (NLSPW) 最新ニュース

Published on: 2025-08-13 08:40:21 - Newser

Can NLS Pharmaceutics AG recover in the next quarterJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - Newser

Does NLS Pharmaceutics AG fit your quant trading modelWeekly Profit Analysis & AI Enhanced Trading Alerts - Newser

NLS Pharmaceutics AG stock chart pattern explainedTrade Analysis Summary & Reliable Price Breakout Alerts - Newser

Using data models to predict NLS Pharmaceutics AG stock movementJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser

How NLS Pharmaceutics AG stock performs during market volatility2025 Price Momentum & Short-Term Trading Alerts - Newser

Can trapped investors hope for a rebound in NLS Pharmaceutics AG2025 Macro Impact & Weekly Watchlist for Consistent Profits - Newser

Building trade automation scripts for NLS Pharmaceutics AGMachine Learning Intraday Signal Forecast - Newser

Order flow analysis tools used on NLS Pharmaceutics AGOil Prices & Weekly Top Gainers Trade List - Newser

Custom watchlist performance reports with NLS Pharmaceutics AGTrade Setup Builder with Custom Alerts - Newser

Chart based exit strategy for NLS Pharmaceutics AG Equity Warrant [Quarterly Earnings Summary]Community Verified Watchlist Alerts - Newser

Analyzing net buyer seller activity in NLS Pharmaceutics AGFree High Win Rate Trading Opportunities - Newser

How to escape a deep drawdown in NLS Pharmaceutics AGBreakout Stock Opportunities with Low Drawdown - Newser

How to escape a deep drawdown in NLS Pharmaceutics AG Equity WarrantBreakout Stock Opportunities with Low Drawdown - Newser

Analyzing NLS Pharmaceutics AG with multi timeframe chartsBuy Signal System Based on Price Action - Newser

Chart based exit strategy for NLS Pharmaceutics AG Equity WarrantAI Volatility Forecast and Risk Monitor - Newser

Is NLS Pharmaceutics AG Equity Warrant still worth holding after the dipConservative Equity Setup with Signal Analysis - Newser

How NLS Pharmaceutics AG stock reacts to Fed policy changesMulti-Year Investment Performance Summary Report - Newser

Heatmap analysis for NLS Pharmaceutics AG and competitorsWeekly High Conviction Trade Setup Analysis - Newser

Long term hold vs stop loss in NLS Pharmaceutics AG Equity WarrantShort-Term Upside Breakout Forecast System - Newser

Developing predictive dashboards with NLS Pharmaceutics AG Equity Warrant dataFree Entry and Exit Strategy Optimizer Tool - Newser

What machine learning models say about NLS Pharmaceutics AG Equity WarrantBuy Zone Strategy with Pattern Recognition - Newser

Why NLS Pharmaceutics AG Equity Warrant stock attracts strong analyst attentionBuy/Sell Zone Confirmation Technical Analysis - Newser

Can momentum traders help lift NLS Pharmaceutics AG Equity WarrantFree Opportunity Map for Daily Stock Trading - Newser

Will NLS Pharmaceutics AG Equity Warrant stock recover after recent dropWeekly Stock Picks with Trend Confidence - Newser

NLS Pharmaceutics Regains Compliance With Nasdaq Stockholders' Equity Requirement - 富途牛牛

NLS Pharmaceutics (NASDAQ:NLSP) Rating Increased to Hold at Wall Street Zen - Defense World

Can technical indicators confirm NLS Pharmaceutics AG’s reversalRSI and MACD Signal Summary with Trends - Newser

Volume spikes in NLS Pharmaceutics AG stock – what they meanBuy Signal System Based on Price Action - Newser

Risk adjusted return profile for NLS Pharmaceutics AG Equity Warrant analyzedHigh Probability Trade Outcome Prediction - Newser

Does NLS Pharmaceutics AG Equity Warrant stock pay reliable dividendsTechnical Confirmation System with Signal Alerts - Newser

RPRX

$36.46

1.67%

INCY

$85.85

5.20%

SMMT

$26.87

4.61%

INSM

$122.87

0.71%

BNTX

$112.78

1.60%

ONC

$307.51

6.74%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く